News Quantified

TRDA – entrada therapeutics, inc. (US:NASDAQ)

Entrada Therapeutics (TRDA) had its price target raised by Oppenheimer Holdings, Inc. from $21.00 to $23.00. They now have an "outperform" rating on the stock.

4/1

09:00 am

trda

Medium

Entrada Therapeutics (TRDA) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.

Entrada Therapeutics (TRDA) was downgraded by Wall Street Zen from "h

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Entrada Therapeutics (TRDA) was upgraded by Wall Street Zen from "sel

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}